The Japan Times - US tycoon opens Africa's first start-to-finish Covid-19 jab plant

EUR -
AED 3.824588
AFN 79.136766
ALL 98.140077
AMD 415.198572
ANG 1.877
AOA 951.206991
ARS 1090.486799
AUD 1.659721
AWG 1.8769
AZN 1.77027
BAM 1.950501
BBD 2.102797
BDT 127.004944
BGN 1.953324
BHD 0.39241
BIF 3035.319506
BMD 1.041276
BND 1.409278
BOB 7.196276
BRL 6.188404
BSD 1.041475
BTN 90.0418
BWP 14.404795
BYN 3.408257
BYR 20409.00937
BZD 2.092026
CAD 1.498131
CDF 2962.430314
CHF 0.943919
CLF 0.037409
CLP 1032.216479
CNY 7.572367
CNH 7.581864
COP 4431.930925
CRC 523.779474
CUC 1.041276
CUP 27.593814
CVE 110.686698
CZK 25.153579
DJF 185.055798
DKK 7.460576
DOP 63.945061
DZD 140.671177
EGP 52.386801
ERN 15.61914
ETB 131.252866
FJD 2.409304
FKP 0.857581
GBP 0.845332
GEL 2.978331
GGP 0.857581
GHS 15.826542
GIP 0.857581
GMD 76.012826
GNF 9013.2845
GTQ 8.050129
GYD 217.785169
HKD 8.109879
HNL 26.555912
HRK 7.684146
HTG 136.001156
HUF 410.658428
IDR 16916.257323
ILS 3.689343
IMP 0.857581
INR 90.03044
IQD 1364.071545
IRR 43837.718673
ISK 146.1015
JEP 0.857581
JMD 163.41602
JOD 0.738683
JPY 163.003944
KES 134.845315
KGS 91.059658
KHR 4197.383338
KMF 492.107326
KPW 937.148505
KRW 1495.704412
KWD 0.321027
KYD 0.867938
KZT 542.528625
LAK 22699.816611
LBP 93225.179411
LKR 311.006529
LRD 202.997191
LSL 19.253261
LTL 3.074617
LVL 0.629857
LYD 5.117886
MAD 10.409115
MDL 19.423137
MGA 4914.822946
MKD 61.54156
MMK 3382.023792
MNT 3538.25592
MOP 8.354362
MRU 41.526221
MUR 48.367306
MVR 16.046045
MWK 1808.174035
MXN 21.340061
MYR 4.618578
MZN 66.548137
NAD 19.253034
NGN 1621.266858
NIO 38.316373
NOK 11.742495
NPR 144.06728
NZD 1.837827
OMR 0.400823
PAB 1.041475
PEN 3.871987
PGK 4.167447
PHP 60.981808
PKR 290.151533
PLN 4.223677
PYG 8237.619457
QAR 3.791277
RON 4.975738
RSD 117.149829
RUB 103.345661
RWF 1449.456176
SAR 3.905965
SBD 8.824531
SCR 15.005455
SDG 625.806941
SEK 11.454817
SGD 1.411314
SHP 0.857581
SLE 23.636636
SLL 21835.036753
SOS 595.086376
SRD 36.527702
STD 21552.310629
SVC 9.113241
SYP 13538.670384
SZL 19.253458
THB 35.249276
TJS 11.398458
TMT 3.654879
TND 3.327403
TOP 2.438771
TRY 37.117542
TTD 7.074813
TWD 34.06045
TZS 2629.22167
UAH 43.741759
UGX 3832.605711
USD 1.041276
UYU 45.576175
UZS 13541.794113
VES 57.991537
VND 26125.614546
VUV 123.622376
WST 2.916434
XAF 654.182811
XAG 0.033784
XAU 0.000378
XCD 2.814101
XDR 0.802424
XOF 654.430405
XPF 119.331742
YER 259.329891
ZAR 19.275575
ZMK 9372.736948
ZMW 29.030431
ZWL 335.290443
  • CMSC

    -0.0600

    23.49

    -0.26%

  • CMSD

    -0.0400

    23.96

    -0.17%

  • BCC

    -1.2000

    127.92

    -0.94%

  • GSK

    -0.3500

    33.43

    -1.05%

  • SCS

    -0.2200

    11.58

    -1.9%

  • NGG

    -1.5400

    60.05

    -2.56%

  • BTI

    -0.1600

    36.57

    -0.44%

  • RIO

    -0.6100

    61.12

    -1%

  • AZN

    0.2400

    68.2

    +0.35%

  • RBGPF

    0.1600

    62.36

    +0.26%

  • RYCEF

    0.1500

    7.42

    +2.02%

  • BP

    -0.3900

    31.13

    -1.25%

  • BCE

    -0.2400

    23.15

    -1.04%

  • JRI

    -0.0400

    12.53

    -0.32%

  • RELX

    -0.2900

    49.26

    -0.59%

  • VOD

    -0.1700

    8.38

    -2.03%

US tycoon opens Africa's first start-to-finish Covid-19 jab plant

US tycoon opens Africa's first start-to-finish Covid-19 jab plant

US biotech billionaire Patrick Soon-Shiong on Wednesday opened a plant in Cape Town that will be the first in Africa to produce Covid-19 vaccines from start to finish.

Text size:

The factory should churn out its first vials of second-generation coronavirus vaccine "within the year" and produce a billion doses annually by 2025, Soon-Shiong said.

The plant will be South Africa's third Covid vaccine-manufacturing facility but the first in the continent to make the formula across every stage, rather than producing it from semi-finished batches.

With just 10.9 percent of the 1.3 billion people fully vaccinated, Africa is the least vaccinated continent in the world. This compares with approximately 63 percent in the US and around 70 percent in Europe.

Africa currently manufactures less than one percent of all vaccines administered on the continent, according to the World Health Organization (WHO).

South African President Cyril Ramaphosa, speaking at the inaugural event, hailed the plant as a sign of African self-reliance.

"Africa should no longer be the last in line to access vaccines against pandemics, Africa should no longer go cap in hand to the Western world begging and begging for vaccines," Ramaphosa said.

"We will stand on our own," he vowed, "without the shackles of colonial thinking."

He thanked Soon-Shiong, a South African-born and now United States-based doctor-turned-entrepreneur -- for returning "home" to invest in vaccine production.

Born in South Africa to Chinese parents and now a US citizen, the billionaire said the launch was "one of the momentous moments of my life -- this is a homecoming."

- T-cell vaccine -

After making a fortune by inventing a cancer drug, he founded NantWorks, a California-based startup in healthcare, biotech and artificial intelligence, in 2007.

Production at the state-of-the-art vaccine-manufacturing campus in Cape Town's Brackengate industrial area will be a collaborative effort between NantWorks, South African research institutions and four local universities.

"We have now developed this SN (spike nucleic) T-cell vaccine, a second-generation vaccine, and we want to manufacture this in Africa, for Africa, and export it to the world," Soon-Shiong said.

The vaccine is being developed "all the way from scratch", with self-amplifying RNA (ribonucleic acid) drug substance, to "full finish", the doctor said.

Johnson & Johnson has an operational "fill-and-finish" plant in South Africa, and Pfizer/BioNTech have partnered with Biovac to bottle their mRNA vaccine starting this year.

"We want to migrate from just doing 'fill and finish', to wanting to manufacture the drug substance ourselves," Ramaphosa said.

Meantime, a South African biotech consortium is working on a pilot project to tweak Moderna's mRNA formula, and prototype shots could be available for trial this year.

South Africa and India have been lobbying the World Trade Organization to temporarily suspend intellectual property rights so that Covid-19 vaccines are accessible to poorer countries.

The billionaire's family foundation, along with the Rockefeller Foundation, the US National Institutes of Health, the European Commission and the Bill & Melinda Gates Foundation, have raised more than one billion rand ($65 million, 57 million euros) to fund the project.

Soon-Shiong says that another $195 million will need to be raised to develop the new plant, which will also produce cancer vaccines.

The NantWorks project will also work on cell-based immunotherapies that could lead to new cancer vaccines and treatments.

T.Maeda--JT